---
$id: https://graph.org.ai/products/commodity/51392214
$type: Product
source: UNSPSC
code: "51392214"
title: "Tizanidine"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tizanidine

**UNSPSC Code**: 51392214
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C9H8ClN5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6AI06C00GW, chemically known as 2,1,3-benzothiadiazole, 5-chloro-4-(2-imidazolin-2-ylamino)- but generally known as tizanidine, which bears US NIH Compound Identifier 5487. European Medicines Agency schedules Tizanidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11129MIG. The term TIZANIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules tizanidine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule tizanidine under HS 29349990 and SITC 51579. As of Q4 2014, TIZANIDINE remains the US FDA Preferred Term for this commodity. Tizanidine bears US NLM identifiers UMLS ID C0146011 and NCI Concept Code C61976. SMILES: CLC1C(NC2=NCCN2)C2NSNC2CC1.

